Sickle cell disease (SCD) is a severe hemoglobinopathy punctuated by recurrent painful vaso-occlusive crises (VOC) and by hemolytic anemia mainly due to chronic vascular inflammation and oxidative stress. VOCs are unpredictable and lead to serious multifocal organ damages making difficult the development of effective treatment and explaining why there is still no curative therapy applicable to the entire SCD population. Based on previous studies, the aim of this work was to characterize the effects of i) moderate exercise training ii) the contribution of RAGE (Receptor for advanced glycation end products) which is a modulator of oxidative stress and inflammation, to the vicious circle of SCD. The first study shows that voluntary wheel runni...
The Receptor for Advanced Glycation End products (RAGE) is a ubiquitous transmembrane receptor invol...
La drépanocytose est une hémoglobinopathie génétique ayant pour conséquences une anémie hémolytique ...
Sickle cell disease is a genetic hemoglobinopathy resulting in chronic and severe hemolytic anemia a...
Sickle cell disease (SCD) is a severe hemoglobinopathy punctuated by recurrent painful vaso-occlusiv...
La drépanocytose est une hémoglobinopathie grave caractérisée par des crises vaso-occlusives (CVOs) ...
Sickle cell disease is, in its severe form, a very disabling disease. lt is punctuated by recurrent ...
La drépanocytose est, sous sa forme grave, une pathologie très invalidante pour les personnes qui en...
Sickle cell disease (SCD) and atherosclerosis are two very different and distinct diseases thatshare...
La drépanocytose (SCD) et l’athérosclérose sont deux maladies très diffèrentes et distinctesqui part...
Résumé : Les maladies cardiovasculaires représentent, par une large mesure, la première cause de mor...
International audienceSickle cell disease is a class of hemoglobinopathy in humans, which is the mos...
Sickle cell disease is a genetic hemoglobinopathy resulting in chronic and severe hemolytic anemia a...
The atypical haemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy of which the predomin...
La drépanocytose est la maladie génétique la plus répandue au monde. Elle est caractérisée par la sy...
The Receptor for Advanced Glycation End products (RAGE) is a ubiquitous transmembrane receptor invol...
La drépanocytose est une hémoglobinopathie génétique ayant pour conséquences une anémie hémolytique ...
Sickle cell disease is a genetic hemoglobinopathy resulting in chronic and severe hemolytic anemia a...
Sickle cell disease (SCD) is a severe hemoglobinopathy punctuated by recurrent painful vaso-occlusiv...
La drépanocytose est une hémoglobinopathie grave caractérisée par des crises vaso-occlusives (CVOs) ...
Sickle cell disease is, in its severe form, a very disabling disease. lt is punctuated by recurrent ...
La drépanocytose est, sous sa forme grave, une pathologie très invalidante pour les personnes qui en...
Sickle cell disease (SCD) and atherosclerosis are two very different and distinct diseases thatshare...
La drépanocytose (SCD) et l’athérosclérose sont deux maladies très diffèrentes et distinctesqui part...
Résumé : Les maladies cardiovasculaires représentent, par une large mesure, la première cause de mor...
International audienceSickle cell disease is a class of hemoglobinopathy in humans, which is the mos...
Sickle cell disease is a genetic hemoglobinopathy resulting in chronic and severe hemolytic anemia a...
The atypical haemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy of which the predomin...
La drépanocytose est la maladie génétique la plus répandue au monde. Elle est caractérisée par la sy...
The Receptor for Advanced Glycation End products (RAGE) is a ubiquitous transmembrane receptor invol...
La drépanocytose est une hémoglobinopathie génétique ayant pour conséquences une anémie hémolytique ...
Sickle cell disease is a genetic hemoglobinopathy resulting in chronic and severe hemolytic anemia a...